Company: SHPH
Filing Date: 2025-02-27
Form Type: 8-K
Source: 0001493152-25-008462
Chunk: 1

Company: Shuttle Pharmaceuticals Holdings, Inc.
Filing Date: 2025-02-27
Form: 8-K
Item: Item 9.01
Chunk 1
---
Item
9.01 Financial Statements and Exhibits.

(d)
Exhibits

  Exhibit      Description                                                                                                                                                          
      No.                                                                                                                                                                           
     10.1      Amendment Agreement, dated February 26, 2025, between Shuttle Pharmaceuticals Holdings, Inc. and Alto Opportunity Master Fund, SPC – Segregated Master Portfolio B.  
 ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
      104      Cover                                                                                                                                                                

SIGNATURES

Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.

  SHUTTLE                                                 
  By:                                 /s/                 
  Name:                               Anatoly             
  Title:                              Chief